Voloridge Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.24M | Sell |
135,542
-396,432
| -75% | -$9.47M | 0.01% | 868 |
|
|
2025
Q1 | $13.2M | Buy |
531,974
+415,825
| +358% | +$10.3M | 0.05% | 478 |
|
|
2024
Q4 | $2.19M | Buy |
116,149
+65,467
| +129% | +$1.23M | 0.01% | 928 |
|
|
2024
Q3 | $763K | Sell |
50,682
-13,985
| -22% | -$210K | ﹤0.01% | 1050 |
|
|
2024
Q2 | $1.85M | Sell |
64,667
-123,777
| -66% | -$3.54M | 0.01% | 963 |
|
|
2024
Q1 | $5.51M | Buy |
188,444
+113,990
| +153% | +$3.33M | 0.02% | 642 |
|
|
2023
Q4 | $2.51M | Buy |
74,454
+40,044
| +116% | +$1.35M | 0.01% | 778 |
|
|
2023
Q3 | $1.06M | Buy |
+34,410
| New | +$1.06M | 0.01% | 1083 |
|
|
2021
Q4 | – | Sell |
-80,849
| Closed | -$4.53M | – | 1781 |
|
|
2021
Q3 | $4.53M | Buy |
80,849
+46,562
| +136% | +$2.61M | 0.03% | 723 |
|
|
2021
Q2 | $2.08M | Buy |
34,287
+30,481
| +801% | +$1.85M | 0.01% | 981 |
|
|
2021
Q1 | $267K | Sell |
3,806
-109,886
| -97% | -$7.71M | ﹤0.01% | 1272 |
|
|
2020
Q4 | $6.8M | Buy |
113,692
+3,235
| +3% | +$194K | 0.06% | 375 |
|
|
2020
Q3 | $6.64M | Buy |
+110,457
| New | +$6.64M | 0.06% | 366 |
|
|
2020
Q1 | – | Sell |
-7,513
| Closed | -$340K | – | 1319 |
|
|
2019
Q4 | $340K | Buy |
+7,513
| New | +$340K | 0.01% | 901 |
|
|
2019
Q2 | – | Sell |
-14,903
| Closed | -$567K | – | 993 |
|
|
2019
Q1 | $567K | Sell |
14,903
-12,313
| -45% | -$468K | 0.02% | 633 |
|
|
2018
Q4 | $1.17M | Sell |
27,216
-28,910
| -52% | -$1.24M | 0.05% | 252 |
|
|
2018
Q3 | $2.76M | Buy |
+56,126
| New | +$2.76M | 0.06% | 187 |
|